MedPath

Assessing the Effect of Haridru twak in the management of Vyanga (Melasma)

Phase 3
Conditions
Health Condition 1: L819- Disorder of pigmentation, unspecified
Registration Number
CTRI/2024/06/069476
Lead Sponsor
Post Graduate Institute of Ayurveda DSRRAU Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients presenting Vyanga as clinical features according to Sushruta Samhita.

2. Patients of either sex.

3. Patients of age between 16 - 45 years.

Exclusion Criteria

1. Age less than 16 years and more than 45 years.

2. Patient with present and past history of any skin disease i.e. psoriasis, eczema etc.

3. Vyanga [Hyper pigmentation] caused due to any systemic disease like Cushing syndrome, Addison disease etc.

4. Vyanga [Hyper pigmentation] present since birth.

5. Vyanga [Hyper pigmentation] caused by Tumor like malignant melanoma.

6. History of hypersensitivity.

7. Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in <br/ ><br>1.MASI ( MELASMA AREA SEVERITY INDEX) SCORE <br/ ><br>2. COLOR GRADING SCALETimepoint: 45 days
Secondary Outcome Measures
NameTimeMethod
CHANGES IN <br/ ><br>1. CBC , ESR <br/ ><br>2. URINE ROUTINE <br/ ><br>3. PHOTOGRAPHY OF THE AFFECTED PARTTimepoint: 45 days
© Copyright 2025. All Rights Reserved by MedPath